Journal
VACCINE
Volume 29, Issue 13, Pages 2451-2460Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2011.01.014
Keywords
Malaria vaccine; PfMSP1(19); Gold nanoparticles based delivery
Categories
Funding
- University Grants Commission (UGC), India
- Indian Council of Medical Research (ICMR)
- ICGEB, New Delhi
Ask authors/readers for more resources
The C-terminal 19 kDa fragment of merozoite surface protein 1(MSP-1(19)) is an important vaccine candidate but a poor immunogen with available human compatible adjuvants like alum. We have investigated if Gold Nanoparticles (GNPs) based delivery system would enhance immune response to recombinant PfMSP-1(19) and PvMSP-1(19). We found that PfMSP-1(19)/PvMSP-1(19) coated on GNPs or in alum was poorly immunogenic in mice, a robust antibody response was observed when PfMSP-1(19)/PvMSP-1(19) coated GNPs were formulated with alum. PfMSP-1(19)/PvMSP-1(19) coated GNPs strongly recognized conformation specific monoclonal antibodies showing that capping on to GNPs did not compromise with conformational integrity of these antigens, which is critical for the generation of functional antibody response. Anti-PfMSP-1(19) antibodies raised with GNP-alum formulation recognized the native protein on parasite surface and showed invasion inhibition of Plasmodium falciparum parasite in an in vitro assay. Antigen coated GNPs with alum may be useful in the development of an alternate adjuvant formulation. (C) 2011 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available